Activity of lipophilic and hydrophilic drugs against dormant and replicating Mycobacterium tuberculosis
作者： Giovanni Piccaro , Giovanna Poce , Mariangela Biava , Federico Giannoni , Lanfranco Fattorini
DOI: 10.1038/JA.2015.52
关键词:
摘要: Activity of lipophilic and hydrophilic drugs against dormant replicating Mycobacterium tuberculosis
nature.com
researchgate.net 
sci-hub.se 参考文章(25)
Jaiyanth Daniel, Tatiana Sirakova, Pappachan Kolattukudy, An Acyl-CoA Synthetase in Mycobacterium tuberculosis Involved in Triacylglycerol Accumulation during Dormancy PLoS ONE. ,vol. 9, pp. e114877- ,(2014) , 10.1371/JOURNAL.PONE.0114877
Giovanna Poce, Robert H. Bates, Salvatore Alfonso, Martina Cocozza, Giulio Cesare Porretta, Lluís Ballell, Joaquin Rullas, Fátima Ortega, Alessandro De Logu, Emanuela Agus, Valentina La Rosa, Maria Rosalia Pasca, Edda De Rossi, Baojie Wae, Scott G. Franzblau, Fabrizio Manetti, Maurizio Botta, Mariangela Biava, Improved BM212 MmpL3 inhibitor analogue shows efficacy in acute murine model of tuberculosis infection. PLOS ONE. ,vol. 8, ,(2013) , 10.1371/JOURNAL.PONE.0056980
Robert C. Goldman, Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis? Tuberculosis. ,vol. 93, pp. 569- 588 ,(2013) , 10.1016/J.TUBE.2013.09.003
Giovanna Poce, Martina Cocozza, Sara Consalvi, Mariangela Biava, SAR analysis of new anti-TB drugs currently in pre-clinical and clinical development European Journal of Medicinal Chemistry. ,vol. 86, pp. 335- 351 ,(2014) , 10.1016/J.EJMECH.2014.08.066
Alimuddin I Zumla, Stephen H Gillespie, Michael Hoelscher, Patrick P J Philips, Stewart T Cole, Ibrahim Abubakar, Timothy D McHugh, Marco Schito, Markus Maeurer, Andrew J Nunn, New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects Lancet Infectious Diseases. ,vol. 14, pp. 327- 340 ,(2014) , 10.1016/S1473-3099(13)70328-1
Véronique Dartois, The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells Nature Reviews Microbiology. ,vol. 12, pp. 159- 167 ,(2014) , 10.1038/NRMICRO3200
Yousef Dashti, Tanja Grkovic, Ronald J. Quinn, Predicting natural product value, an exploration of anti-TB drug space Nat. Prod. Rep.. ,vol. 31, pp. 990- 998 ,(2014) , 10.1039/C4NP00021H
AY Coban, K Bilgin, N Tasdelen Fisgin, M Uzun, B Durupinar, None, Effect of Meropenem against Multidrug-ResistantMycobacterium tuberculosis Journal of Chemotherapy. ,vol. 20, pp. 395- 396 ,(2008) , 10.1179/JOC.2008.20.3.395
Doris Hillemann, Sabine Rüsch-Gerdes, Elvira Richter, In vitro-selected linezolid-resistant Mycobacterium tuberculosis mutants. Antimicrobial Agents and Chemotherapy. ,vol. 52, pp. 800- 801 ,(2008) , 10.1128/AAC.01189-07
Joanna Bacon, Luke J. Alderwick, Jon A. Allnutt, Evelina Gabasova, Robert Watson, Kim A. Hatch, Simon O. Clark, Rose E. Jeeves, Alice Marriott, Emma Rayner, Howard Tolley, Geoff Pearson, Graham Hall, Gurdyal S. Besra, Lorenz Wernisch, Ann Williams, Philip D. Marsh, Non-Replicating Mycobacterium tuberculosis Elicits a Reduced Infectivity Profile with Corresponding Modifications to the Cell Wall and Extracellular Matrix PLoS ONE. ,vol. 9, pp. e87329- ,(2014) , 10.1371/JOURNAL.PONE.0087329